Access the full text.
Sign up today, get DeepDyve free for 14 days.
References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.
The division cycle of normal mammalian cells is governed by a highly coordinated network of interacting mechanisms that ensure a correct succession of the biochemical and biophysical events culminating in mitosis. A family of specific protein kinases, the Cdks, constitute the motor element of cell cycle progression. Their function is regulated at several levels: 1. association with a cyclin subunit situates their activity in different phases of the cell cycle; 2. sequential phosphorylation and dephosphorylation on specific amino acid residues is required for their final activation; 3. their activity can be modulated by complexing with members of the cyclin-dependent kinase inhibitor family (Cdkls). The latter function to a large extent as effectors of signals emitted by cell surface receptors or internal sensors of defective biochemical and biophysical states termed checkpoints. While the fate of cells is largely influenced by external factors throughout Gl phase, an intrinsic program becomes responsible for cell cycle progression after the passage of the ‘restriction point’ at the Gl/S boundary. This crucial transition is controlled by a checkpoint mechanism in which the concerted action of p53 and the retinoblastoma protein may induce either a cell cycle arrest or apoptosis in response to genomic damage. Several other checkpoint functions regulate the entry into mitosis by assessing the completion of DNA replication and correct chromosome attachment to the spindle apparatus. Finally, the number of possible cell divisions is predetermined by the number of small oligonucleotide repeats at the utmost chromosome ends, the telomeres. Checkpoint mechanisms can be disrupted by viral oncoproteins or gene mutations. Loss of their function is likely to result in genomic destabili-zation and gene amplification, which again may allow for chromosome aberrations and, as several connections link the genome to the cell cycle machinery, may permit unrestrained cell growth. The majority of the cell cycle-related proteins, however, do not qualify for monitoring the prolifer-ative activity or the tumor growth fraction. To date, only three proteins: p345 (Ki-67), pl70 (topoisomerase II-alpha), and p100 (S-phase protein) have been identified as selective indicators of cellular proliferation. The first two recognize all cell cycle phases except GO, whereas the latter is specifically expressed in S, G2, and M phase cells. Application of antibodies to these proteins in clinical pathology was found to be highly relevant for the prediction of tumor biology and clinical courses.
Oncology Research and Treatment – Karger
Published: Jan 1, 1996
Keywords: Checkpoint; p53; Rb; Cell cycle; Cyclin; Cyclin-dependent kinase; Cyclin-kinase inhibitors
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.